Learning Module Catalogue
Search Learning Modules
The Endocannabinoid System in Health and Disease
The endocannabinoid system is a major regulatory system in the body, responsible for regulating nearly all our bodily systems and functions. In this foundation module, neuroscientist Dr Elisabeth Philipps presents an overview of the endocannabinoid system, covering its components, distribution and roles including in stress modulation, pain, inflammation, neuroinflammation and more.
This module is suitable for healthcare practitioners and others with a background in biomedical sciences.
Dr Elisabeth Philipps, PhD
50
Cannabis as an Orchestra of Components for a Multitude of Conditions
This learning module presents an overview of medicinal cannabis by one of Israel’s leading experts, Dr David (Dedi) Meiri. Dr Meiri explores the endocannabinoid system and the many constituents of cannabis, and shares some of his research findings including evidence of specificity of cannabis cultivars in relation to cancer cells, and demonstrating the concept of polypharmacy in relation to cannabis.
Dr Dedi Meiri
50
Case Studies in Dementia and Palliative Care
Dr Zac Baran
50
Medicinal Cannabis in Paediatric Developmental Disorders
Daryl Efron
50
Overview of Medicinal Cannabis: Foundations
In this learning module, we explore what medicinal cannabis is, including its history of use, the major components of cannabis (cannabidiol [CBD], tetrahydrocannabinol [THC], terpenes), and the major therapeutic actions of THC and CBD and their mechanisms of action. We also examine what people are using medicinal cannabis for, evidence of its efficacy and briefly cover safety in relation to THC and CBD.
This learning module is suitable for healthcare practitioners with an interest in learning about medicinal cannabis.
Prof. Kylie O'Brien
50
Cannabis Pharmacokinetics
In this presentation, pharmacology expert Associate Professor Ali Seyfoddin (New Zealand) takes us through the pharmacokinetics of medicinal cannabis, covering the routes of delivery of cannabis (inhalation, oral, buccal, rectal and transdermal routes) and the associated absorption characteristics, distribution, metabolism and elimination. THC bioavailability, time for maximum plasma concentrations, and potential for drug-cannabinoid interactions is also examined.
This presentation is suitable for healthcare practitioners and those with a background in biomedical sciences. It assumes a knowledge of the endocannabinoid system and medicinal cannabis pharmacodynamics.
Ali Seyfoddin
50
Cannabis and Driving
In this presentation, Associate Professor Ali Seyfoddin gives a summary of the safety aspects of cannabis, tetrahydrocannabinol (THC) and cannabidiol (CBD) including common side effects, drug-cannabis interactions, and contraindications. He also explores some of the scientific evidence of safety of cannabis in the treatment of specific illnesses, as well as safety in relation to long-term use.
This presentation is suitable for healthcare practitioners and those with a background in biomedical sciences. It assumes a knowledge of the endocannabinoid system and medicinal cannabis pharmacodynamics.
Dr Thomas Arkell
50
Prescribing Cannabis for Symptom Management in Cancer Patients
Cancer is rapidly becoming the number one cause of mortality in many countries. Increasingly people diagnosed with cancer are turning to medicinal cannabis to treat symptoms/signs associated with cancer and its treatments. In this presentation, Associate Professor Judith Professor of the Chris O’Brien Lifehouse Comprehensive Cancer Centre, shares her experience in cancer and cancer treatment symptom management, including its use in treating refractory symptoms in advanced cancer.
This presentation assumes an understanding of the endocannabinoid system and how CBD and THC work. This presentation is pitched at the level of healthcare practitioners and those with a background in biomedical sciences.
Judith Lacey
50
Safety of Medicinal Cannabis
In this presentation, Associate Professor Ali Seyfoddin gives a summary of the safety aspects of cannabis, tetrahydrocannabinol (THC) and cannabidiol (CBD) including common side effects, drug-cannabis interactions, and contraindications. He also explores some of the scientific evidence of safety of cannabis in the treatment of specific illnesses, as well as safety in relation to long-term use.
This presentation is suitable for healthcare practitioners and those with a background in biomedical sciences. It assumes a knowledge of the endocannabinoid system and medicinal cannabis pharmacodynamics.
Ali Seyfoddin
50
Safety of Medicinal Cannabis
In this presentation, you will learn about the safety aspects of cannabis, tetrahydrocannabinol (THC) and cannabidiol (CBD) including common and rarer side effects, effects on blood pressure and heart rate, toxicity and drug-cannabis/THC/CBD interactions. Safety of terpenes will also be covered.
This presentation is suitable for healthcare practitioners and those with a background in biomedical sciences. It assumes a knowledge of the endocannabinoid system and medicinal cannabis pharmacodynamics.
Prof. Kylie O'Brien
50
Become a Member of the ICCM
- Access to all learning modules (educational videos and self-quizzes) in the ICCM library
- Certificate of Completion for each learning module (on successful completion of self-quiz)
- Free access to regular live online ICCM webinars
- Discounts on ICCM online and face-to-face courses